FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2028200045> ?p ?o ?g. }

• W2028200045 endingPage "1299" @default.
• W2028200045 startingPage "1291" @default.
• W2028200045 abstract "In Brief OBJECTIVE: To compare the efficacy and safety of denosumab to ibandronate in postmenopausal women with low bone mineral density (BMD) previously treated with a bisphosphonate. METHODS: In a randomized, open-label study, postmenopausal women received 60 mg denosumab subcutaneously every 6 months (n=417) or 150 mg ibandronate orally every month (n=416) for 12 months. End points included percentage change from baseline in total hip, femoral neck, and lumbar spine BMD at month 12 and percentage change from baseline in serum C-telopeptide at months 1 and 6 in a substudy. RESULTS: At month 12, significantly greater BMD gains from baseline were observed with denosumab compared with ibandronate at the total hip (2.3% compared with 1.1%), femoral neck (1.7% compared with 0.7%), and lumbar spine (4.1% compared with 2.0%; treatment difference P<.001 at all sites). At month 1, median change in serum C-telopeptide from baseline was −81.1% with denosumab and –35.0% with ibandronate (P<.001); the treatment difference remained significant at month 6 (P<.001). Adverse events occurred in 245 (59.6%) denosumab-treated women and 230 (56.1%) ibandronate-treated women (P=.635). The incidence of serious adverse events was 9.5% for denosumab-treated women and 5.4% for ibandronate-treated women (P=.046). No clustering of events in any organ system accounted for the preponderance of these reports. The incidence rates of serious adverse events involving infection and malignancy were similar between treatment groups. CONCLUSION: In postmenopausal women previously treated with a bisphosphonate and low BMD, denosumab treatment resulted in greater BMD increases than ibandronate at all measured sites. No new safety risks with denosumab treatment were identified. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, www.clinicaltrials.gov, NCT00936897. LEVEL OF EVIDENCE: I Women previously treated with bisphosphonates have greater bone mineral density gains when transitioned to denosumab than to ibandronate." @default.
• W2028200045 created "2016-06-24" @default.
• W2028200045 creator A5008087011 @default.
• W2028200045 creator A5008297260 @default.
• W2028200045 creator A5010429279 @default.
• W2028200045 creator A5018289238 @default.
• W2028200045 creator A5034308578 @default.
• W2028200045 creator A5045290077 @default.
• W2028200045 creator A5047765782 @default.
• W2028200045 creator A5052918389 @default.
• W2028200045 creator A5053948090 @default.
• W2028200045 creator A5063179824 @default.
• W2028200045 creator A5068621774 @default.
• W2028200045 creator A5070407771 @default.
• W2028200045 creator A5072305749 @default.
• W2028200045 creator A5075505037 @default.
• W2028200045 date "2013-06-01" @default.
• W2028200045 modified "2023-10-16" @default.
• W2028200045 title "Denosumab Compared With Ibandronate in Postmenopausal Women Previously Treated With Bisphosphonate Therapy" @default.
• W2028200045 cites W175660244 @default.
• W2028200045 cites W18924068 @default.
• W2028200045 cites W1971112474 @default.
• W2028200045 cites W1988985184 @default.
• W2028200045 cites W1990771263 @default.
• W2028200045 cites W2021748249 @default.
• W2028200045 cites W2028721164 @default.
• W2028200045 cites W2029620076 @default.
• W2028200045 cites W2048299560 @default.
• W2028200045 cites W2048541373 @default.
• W2028200045 cites W2048964656 @default.
• W2028200045 cites W2057332307 @default.
• W2028200045 cites W2059670446 @default.
• W2028200045 cites W2067598175 @default.
• W2028200045 cites W2081417842 @default.
• W2028200045 cites W2087574295 @default.
• W2028200045 cites W2096884368 @default.
• W2028200045 cites W2104372323 @default.
• W2028200045 cites W2104922575 @default.
• W2028200045 cites W2106406207 @default.
• W2028200045 cites W2108258946 @default.
• W2028200045 cites W2109238714 @default.
• W2028200045 cites W2113162921 @default.
• W2028200045 cites W2118914286 @default.
• W2028200045 cites W2122467899 @default.
• W2028200045 cites W2124527463 @default.
• W2028200045 cites W2133551420 @default.
• W2028200045 cites W2139996507 @default.
• W2028200045 cites W2153009489 @default.
• W2028200045 cites W2160005424 @default.
• W2028200045 cites W2161837912 @default.
• W2028200045 cites W2163058169 @default.
• W2028200045 cites W2168410488 @default.
• W2028200045 cites W2335178464 @default.
• W2028200045 doi "https://doi.org/10.1097/aog.0b013e318291718c" @default.
• W2028200045 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23812464" @default.
• W2028200045 hasPublicationYear "2013" @default.
• W2028200045 type Work @default.
• W2028200045 sameAs 2028200045 @default.
• W2028200045 citedByCount "109" @default.
• W2028200045 countsByYear W20282000452013 @default.
• W2028200045 countsByYear W20282000452014 @default.
• W2028200045 countsByYear W20282000452015 @default.
• W2028200045 countsByYear W20282000452016 @default.
• W2028200045 countsByYear W20282000452017 @default.
• W2028200045 countsByYear W20282000452018 @default.
• W2028200045 countsByYear W20282000452019 @default.
• W2028200045 countsByYear W20282000452020 @default.
• W2028200045 countsByYear W20282000452021 @default.
• W2028200045 countsByYear W20282000452022 @default.
• W2028200045 countsByYear W20282000452023 @default.
• W2028200045 crossrefType "journal-article" @default.
• W2028200045 hasAuthorship W2028200045A5008087011 @default.
• W2028200045 hasAuthorship W2028200045A5008297260 @default.
• W2028200045 hasAuthorship W2028200045A5010429279 @default.
• W2028200045 hasAuthorship W2028200045A5018289238 @default.
• W2028200045 hasAuthorship W2028200045A5034308578 @default.
• W2028200045 hasAuthorship W2028200045A5045290077 @default.
• W2028200045 hasAuthorship W2028200045A5047765782 @default.
• W2028200045 hasAuthorship W2028200045A5052918389 @default.
• W2028200045 hasAuthorship W2028200045A5053948090 @default.
• W2028200045 hasAuthorship W2028200045A5063179824 @default.
• W2028200045 hasAuthorship W2028200045A5068621774 @default.
• W2028200045 hasAuthorship W2028200045A5070407771 @default.
• W2028200045 hasAuthorship W2028200045A5072305749 @default.
• W2028200045 hasAuthorship W2028200045A5075505037 @default.
• W2028200045 hasConcept C120665830 @default.
• W2028200045 hasConcept C121332964 @default.
• W2028200045 hasConcept C125870589 @default.
• W2028200045 hasConcept C126322002 @default.
• W2028200045 hasConcept C126894567 @default.
• W2028200045 hasConcept C131075544 @default.
• W2028200045 hasConcept C141071460 @default.
• W2028200045 hasConcept C160160445 @default.
• W2028200045 hasConcept C181199279 @default.
• W2028200045 hasConcept C185592680 @default.
• W2028200045 hasConcept C197934379 @default.
• W2028200045 hasConcept C2775854910 @default.
• W2028200045 hasConcept C2776286101 @default.

• next